| pubmed-article:8054253 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8054253 | lifeskim:mentions | umls-concept:C0001554 | lld:lifeskim |
| pubmed-article:8054253 | lifeskim:mentions | umls-concept:C0001565 | lld:lifeskim |
| pubmed-article:8054253 | lifeskim:mentions | umls-concept:C0155709 | lld:lifeskim |
| pubmed-article:8054253 | lifeskim:mentions | umls-concept:C0042523 | lld:lifeskim |
| pubmed-article:8054253 | lifeskim:mentions | umls-concept:C1261322 | lld:lifeskim |
| pubmed-article:8054253 | lifeskim:mentions | umls-concept:C0205178 | lld:lifeskim |
| pubmed-article:8054253 | lifeskim:mentions | umls-concept:C1273870 | lld:lifeskim |
| pubmed-article:8054253 | lifeskim:mentions | umls-concept:C0439611 | lld:lifeskim |
| pubmed-article:8054253 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:8054253 | pubmed:dateCreated | 1994-9-15 | lld:pubmed |
| pubmed-article:8054253 | pubmed:abstractText | The antiarrhythmic properties of sublingual verapamil were investigated in seven patients with acute fast atrial flutter (n = 2) or fibrillation (n = 5). A rapid and significant (P < 0.05) reduction in the ventricular rate was achieved in all seven patients. The ventricular rate at peak plasma verapamil concentration (+/- s.d.) was significantly slower than on admission (101.6 +/- 11.3 and 159 +/- 5.3 beats min-1 respectively, P < 0.01). The ventricular rate remained controlled for over 4 h. Sublingual verapamil was rapidly absorbed with the maximum peak plasma concentration (153.3 +/- 15.5 ng ml-1) being achieved after 1.21 +/- 0.18 h. Side-effects of sublingual verapamil were limited to one report of a bitter taste. The sublingual administration of verapamil may provide an alternative method for the control of acute fast atrial fibrillation and flutter in selected patients. | lld:pubmed |
| pubmed-article:8054253 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8054253 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8054253 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8054253 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8054253 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8054253 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8054253 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8054253 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8054253 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8054253 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8054253 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8054253 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8054253 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8054253 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8054253 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8054253 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8054253 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8054253 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8054253 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8054253 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8054253 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8054253 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8054253 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8054253 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:8054253 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8054253 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8054253 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8054253 | pubmed:month | May | lld:pubmed |
| pubmed-article:8054253 | pubmed:issn | 0306-5251 | lld:pubmed |
| pubmed-article:8054253 | pubmed:author | pubmed-author:LuscombeD KDK | lld:pubmed |
| pubmed-article:8054253 | pubmed:author | pubmed-author:LewisM JMJ | lld:pubmed |
| pubmed-article:8054253 | pubmed:author | pubmed-author:FortSS | lld:pubmed |
| pubmed-article:8054253 | pubmed:author | pubmed-author:JohnD NDN | lld:pubmed |
| pubmed-article:8054253 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8054253 | pubmed:volume | 37 | lld:pubmed |
| pubmed-article:8054253 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8054253 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8054253 | pubmed:pagination | 460-3 | lld:pubmed |
| pubmed-article:8054253 | pubmed:dateRevised | 2009-11-18 | lld:pubmed |
| pubmed-article:8054253 | pubmed:meshHeading | pubmed-meshheading:8054253-... | lld:pubmed |
| pubmed-article:8054253 | pubmed:meshHeading | pubmed-meshheading:8054253-... | lld:pubmed |
| pubmed-article:8054253 | pubmed:meshHeading | pubmed-meshheading:8054253-... | lld:pubmed |
| pubmed-article:8054253 | pubmed:meshHeading | pubmed-meshheading:8054253-... | lld:pubmed |
| pubmed-article:8054253 | pubmed:meshHeading | pubmed-meshheading:8054253-... | lld:pubmed |
| pubmed-article:8054253 | pubmed:meshHeading | pubmed-meshheading:8054253-... | lld:pubmed |
| pubmed-article:8054253 | pubmed:meshHeading | pubmed-meshheading:8054253-... | lld:pubmed |
| pubmed-article:8054253 | pubmed:meshHeading | pubmed-meshheading:8054253-... | lld:pubmed |
| pubmed-article:8054253 | pubmed:meshHeading | pubmed-meshheading:8054253-... | lld:pubmed |
| pubmed-article:8054253 | pubmed:meshHeading | pubmed-meshheading:8054253-... | lld:pubmed |
| pubmed-article:8054253 | pubmed:meshHeading | pubmed-meshheading:8054253-... | lld:pubmed |
| pubmed-article:8054253 | pubmed:meshHeading | pubmed-meshheading:8054253-... | lld:pubmed |
| pubmed-article:8054253 | pubmed:year | 1994 | lld:pubmed |
| pubmed-article:8054253 | pubmed:articleTitle | Preliminary investigation of the efficacy of sublingual verapamil in the management of acute atrial fibrillation and flutter. | lld:pubmed |
| pubmed-article:8054253 | pubmed:affiliation | Cardiology Department, Western General Hospital, Edinburgh. | lld:pubmed |
| pubmed-article:8054253 | pubmed:publicationType | Journal Article | lld:pubmed |
